Immune Checkpoint Blockade (ICB) has reshaped cancer care and can deliver durable remission in malignancies such as melanoma and non-small cell lung cancer.
Please provide your email address to receive an email when new articles are posted on . An AI tool outperformed current FDA-approved biomarkers for predicting survival after immune checkpoint ...
Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell function and overcome resistance to immune checkpoint ...
Tel Aviv, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, ...
LLMs change the security model by blurring boundaries and introducing new risks. Here's why zero-trust AI is emerging as the ...
Artificial intelligence (AI)-aided analysis of pathology slides showed potential as a predictive biomarker for non-small cell lung cancer (NSCLC) response to immune checkpoint inhibitors (ICIs), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results